Clinical trial
A Multicenter, Open Label Study of QRX003 Lotion in Subjects With Netherton Syndrome
NCT05789056 is registered in ClinicalTrials.gov with Quoin Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open Label Study of QRX003 Lotion in Subjects With Netherton Syndrome
- Lead sponsor
- Quoin Pharmaceuticals
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- March 14, 2023
- Completion date
- December 30, 2026
- Enrollment
- 20 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.